n-benzyladriamycin-14-valerate has been researched along with 3'-deamino-3'-hydroxydoxorubicin in 1 studies
Studies (n-benzyladriamycin-14-valerate) | Trials (n-benzyladriamycin-14-valerate) | Recent Studies (post-2010) (n-benzyladriamycin-14-valerate) | Studies (3'-deamino-3'-hydroxydoxorubicin) | Trials (3'-deamino-3'-hydroxydoxorubicin) | Recent Studies (post-2010) (3'-deamino-3'-hydroxydoxorubicin) |
---|---|---|---|---|---|
25 | 0 | 3 | 11 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dockter, M; Hosey, LM; Koseki, Y; Lothstein, L; Priebe, W; Sweatman, TW | 1 |
1 other study(ies) available for n-benzyladriamycin-14-valerate and 3'-deamino-3'-hydroxydoxorubicin
Article | Year |
---|---|
N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Doxorubicin; Drug Resistance; Epirubicin; Membrane Glycoproteins; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |